SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-084234
Filing Date
2021-03-17
Accepted
2021-03-17 17:20:59
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A d42343ddefa14a.htm DEFA14A 33652
2 GRAPHIC g42343d1.jpg GRAPHIC 40012
3 GRAPHIC g42343d4.jpg GRAPHIC 814
4 GRAPHIC g42343s.jpg GRAPHIC 44168
  Complete submission text file 0001193125-21-084234.txt   152203
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35238 | Film No.: 21751605
SIC: 2834 Pharmaceutical Preparations